The Fas counterattack: a molecular mechanism of tumor immune privilege.

Authors :: O'Connell J
Bennett MW
O'Sullivan GC
Collins JK
Shanahan F
Source :: Molecular medicine (Cambridge, Mass.) [Mol Med] 1997 May; Vol. 3 (5), pp. 294-300.
Publication Year :: 1997

Subjects :: Animals
Humans
Neoplasms therapy
Oligonucleotides, Antisense therapeutic use
Apoptosis
Neoplasms immunology
Tumor Escape immunology
fas Receptor drug effects
fas Receptor immunology

Tools